Relamorelin

Clinical trial
Calculate Dose

For research use only.

Key Facts

CAS
661472-41-9
Molecular Weight (MW)
790.97 g/mol
Half-life
Not firmly established in public sources; studied as short-acting sc peptide
Unit
mcg
Administration Route
Subcutaneous
Frequency
Per study
Last updated
12/14/2025

Overview

โ€”

Protocol

Dosage Range
Per trial protocol
Frequency
Per study
Cycle
Per study
Administration Route
Subcutaneous
Reconstitution Guide
โ€”

Science

Mechanism of Action

Mechanism of action not fully established in publicly available sources.

Studies are being curated for this entry.

Suggest a study

Benefits

Therapeutic benefits not fully established.

Potential Side Effects

  • Side effects not fully established.

References

References coming soon.

Suggest a reference

Related peptides